
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
, ,
“Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study”, Bmj, vol. 348, p. g1996, 2014.
, “Incidence of prostate, breast, lung and colorectal cancer following new consultation for musculoskeletal pain: a cohort study among UK primary care patients”, Int J Cancer, vol. 133, pp. 713-20, 2013.
, “Incidence of psychoses among drug dependent patients in primary care with no psychiatric history: a retrospective observational matched-cohort study”, The European Journal of Psychiatry, vol. 27, pp. 240-7, 2013.
, “Mortality and cancer in patients with new musculoskeletal episodes: a cohort study”, Br J Gen Pract, vol. 60, pp. e105-11, 2010.
, “Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005”, Schizophr Res, vol. 113, pp. 123-8, 2009.
, “Trends in drug misuse recorded in primary care in the UK from 1998 to 2005”, J Public Health (Oxf), vol. 31, pp. 69-73, 2009.
, “Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases”, Br J Gen Pract, vol. 57, pp. 7-14, 2007.
, “Substance misuse and psychiatric illness: prospective observational study using the general practice research database”, J Epidemiol Community Health, vol. 59, pp. 847-50, 2005.
, “Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales”, J Epidemiol Community Health, vol. 58, pp. 1036-41, 2004.
, “Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?”, Cephalalgia, vol. 20, pp. 732-7, 2000.
,